Characteristic of Paracetamol Overdose Before and During COVID-19 Pandemic, Saudi Arabia, 2019-2020
DOI:
https://doi.org/10.47672/ajhmn.1145Keywords:
Paracetamol overdose, COVID-19, epidemiological trend.Abstract
Purpose: Paracetamol is the most used medication worldwide; due to its analgesic and antipyretic effect; it had been included within the recommended regimen for COVID-19 patients. This study aimed at exploring the changes in the incidence of paracetamol overdose during pandemic compared to pre-pandemic periods.
Methodology: Through a record-based study, all cases of paracetamol overdose who had been reported to the ministry of health in Saudi Arabia in the period between January 2019 and December 2020 were included in the study. Data stored in electronic form were retrieved and analyzed using SPSS version 26. Frequency distribution was used to describe categorical variables.
Findings: Two hundred and forty four paracetamol overdose cases were reported in 2020 (during the pandemic) compared to 449 in 2019 (pre-pandemic) with dominance of females (62.6%) and Saudis (86.7%). Most cases ingested paracetamol orally mainly in solid forms (76.5%), and they were mostly diagnosed as confirmed cases on admission (84.6%). The great majority recovered and discharged (87.8%). The overall annual incidence of paracetamol in (pre-pandemic) was 1.32/100,000 which dropped markedly during pandemic to 0.71/100,000.
Conclusion: There was a general decline in the incidence of paracetamol overdose during COVID-19 pandemic, with relative increase in incidence in home incidents and in children.
Recommendation: Health education to the public to increase their awareness about proper and safe use of paracetamol is highly recommended, as well as introducing instructions and guidelines for practitioners about prescribing it.
Downloads
References
Fathelrahman A. Ten Challenges Associated with Management of Paracetamol Overdose: An Update on Current Practice and Relevant Evidence from Epidemiological and Clinical Studies. J Clin Diagn Res. 2021 Feb 13;15:FE01-6.
Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Brooks DE, Dibert KW, et al. 2019 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 37th Annual Report. Clin Toxicol Phila Pa. 2020 Dec;58(12):1360-541.
Bateman DN, Carroll R, Pettie J, Yamamoto T, Elamin MEMO, Peart L, et al. Effect of the UK's revised paracetamol poisoning management guidelines on admissions, adverse reactions and costs of treatment. Br J Clin Pharmacol. 2014 Sep;78(3):610-8.
Ayonrinde OT, Phelps GJ, Hurley JC, Ayonrinde OA. Paracetamol overdose and hepatotoxicity at a regional Australian hospital: a 4-year experience. Intern Med J. 2005;35(11):655-60.
O'Rourke M, Garland MR, McCormick PA. Ease of access is a principal factor in the frequency of paracetamol overdose. Ir J Med Sci. 2002 Jul 1;171(3):148-50.
Cairns R, Brown JA, Wylie CE, Dawson AH, Isbister GK, Buckley NA. Paracetamol poisoning-related hospital admissions and deaths in Australia, 2004-2017. Med J Aust. 2019;211(5):218-23.
Velavan TP, Meyer CG. The COVID"19 epidemic. Trop Med Int Health. 2020 Mar;25:278-80.
Gupta R, Misra A. Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc). Diabetes Metab Syndr Clin Res Rev. 2020 May 1;14(3):251-4.
Alghamdi S. Clinical characteristics and treatment outcomes of severe (ICU) COVID-19 patients in Saudi Arabia: A single centre study. Saudi Pharm J. 2021 Oct;29(10):1096-101.
Banerjee A, Chaudhury S. Statistics without tears: Populations and samples. Ind Psychiatry J. 2010;19(1):60-5.
Sheen CL, Dillon JF, Bateman DN, Simpson KJ, Macdonald TM. Paracetamol toxicity: epidemiology, prevention and costs to the health"care system. QJM Int J Med. 2002 Sep 1;95(9):609-19.
Gulmez SE, Larrey D, Pageaux G, Bernuau J, Bissoli F, Horsmans Y, et al. Liver transplant associated with paracetamol overdose: Results from the seven-country SALT study. Br J Clin Pharmacol. 2015 May 1;80.
Alshareef R, Al Zahrani A, Alzahrani A, Ghandoura L. Impact of the COVID-19 lockdown on diabetes patients in Jeddah, Saudi Arabia. Diabetes Metab Syndr Clin Res Rev. 2020 Sep 1;14(5):1583-7.
Gade C, Bøgevig S, Daoud A, Mathiesen PR, Christensen MB, Dalhoff KP, et al. Has the time come to stop routine N-acetylcysteine treatment in young children in Denmark? A review of 300 suspected paracetamol overdoses in children aged 0-6 years. Acta Paediatr. 2022;111(3):667-74.
Heubi JE, Barbacci MB, Zimmerman HJ. Therapeutic misadventures with acetaminophen: Hepatoxicity after multiple doses in children. J Pediatr. 1998 Jan 1;132(1):22-7.
Alander SW, Dowd MD, Bratton SL, Kearns GL. Pediatric Acetaminophen Overdose: Risk Factors Associated With Hepatocellular Injury. Arch Pediatr Adolesc Med. 2000 Apr 1;154(4):346-50.
Hawton K, Ware C, Mistry H, Hewitt J, Kingsbury S, Roberts D, et al. Paracetamol Self-Poisoning Characteristics, Prevention and Harm Reduction. Br J Psychiatry J Ment Sci. 1996 Feb 1;168:43-8.
Why patients choose paracetamol for self poisoning and their knowledge of its dangers | The BMJ [Internet]. [cited 2022 May 20]. Available from: https://www.bmj.com/content/310/6973/164.1.full
Chiew AL, Isbister GK, Kirby KA, Page CB, Chan BSH, Buckley NA. Massive paracetamol overdose: an observational study of the effect of activated charcoal and increased acetylcysteine dose (ATOM-2). Clin Toxicol Phila Pa. 2017 Dec;55(10):1055-65.
Chiew AL, Reith D, Pomerleau A, Wong A, Isoardi KZ, Soderstrom J, et al. Updated guidelines for the management of paracetamol poisoning in Australia and New Zealand. Med J Aust. 2020;212(4):175-83.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Rayyan Saqah, Jaber Sharaheeli, Lamman Abdulkareem
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
